On June 29, 2026, DTP MEDICAL, in collaboration with BAP MEDICAL (The Netherlands), successfully organized a product presentation at BLING KIM Clinic, introducing evidence-based solutions for wound care and scar management following aesthetic procedures.
Featuring Mr. Samson Soon, Product Specialist at BAP MEDICAL, the presentation provided the medical team at BLING KIM Clinic with the latest clinical updates on evidence-based approaches to accelerating wound healing and reducing early scar formation during the unepithelialized phase with DerMel Skin Ointment, followed by the prevention and management of hypertrophic scars and keloids through medical-grade silicone therapy with BAPSCARCARE and CINOSCAR.
Designed for immediate application following wound suturing or invasive dermatological procedures, DerMel Skin Ointment is appreciated for its ability to support optimal wound healing through the triple-action mechanism – “Accelerated Wound Healing – Antibacterial – Anti-inflammatory”.
Early intervention with DerMel Skin Ointment helps create a favorable wound healing environment, reduces the risk of prolonged inflammation and bacterial contamination, promotes re-epithelialization, and ultimately contributes to minimizing abnormal scar formation from the earliest stages of healing.
A key advantage highlighted during the presentation was DerMel Skin Ointment’s soft ointment texture, which spreads smoothly across the wound surface, allowing gentle application with minimal friction while reducing discomfort during dressing changes or topical application. This characteristic makes DerMel Skin Ointment particularly suitable for post-aesthetic surgical wounds and invasive dermatological procedures, where the newly treated skin remains highly sensitive and requires delicate handling.
As the wound progresses beyond the early healing phase and complete re-epithelialization is achieved, the focus of care shifts toward long-term scar prevention and management.
Addressing this clinical need, BAPSCARCARE and CINOSCAR were introduced as evidence-based medical-grade silicone therapies for the prevention and management of hypertrophic scars and keloids. Available in both silicone gel and silicone sheet formulations, the product portfolios provide clinicians with flexible treatment options, enabling individualized scar management based on patient-specific needs.
Together, the combination of DerMel Skin Ointment during the unepithelialized phase and BAPSCARCARE/CINOSCAR following wound closure offers a comprehensive strategy of care, supporting every stage of post-procedure wound healing and scar management.
The presentation concluded with an engaging discussion between the BAP MEDICAL expert and the physicians at BLING KIM Clinic, fostering valuable exchanges on practical approaches to evidence-based wound care and scar management in aesthetic practice.
DTP MEDICAL would like to express our sincere appreciation to the medical team at BLING KIM Clinic for the participation and insightful discussions. We look forward to continuing our journey with you in updating scientific wound care and scar management solutions, helping to improve treatment results and bring the best experience to clients.